Maravai Lifesciences Holdings (MRVI) EBT Margin (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly EBT Margin came in at 9.92% in Q1 2026, up 10255.0% year-on-year from N/an in Q1 2025, and up 92.15% quarter-over-quarter from 126.36% in Q4 2025.
Maravai Lifesciences Holdings (MRVI) EBT Margin (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' EBT Margin history runs 7 years deep, the most recent figure standing at 9.92% for Q1 2026.
- On a quarterly basis, EBT Margin rose 10255.0% year-over-year to 9.92% in Q1 2026; TTM through Mar 2026 was 92.22%, a 2841.0% increase from a year earlier, with the FY2025 full-year figure at 126.5%, down 2562.0% from the prior year.
- EBT Margin advanced to 9.92% in Q1 2026 per MRVI's latest filing, from 126.36% in the prior quarter.
- Across five years, EBT Margin topped out at 885.05% in Q4 2023 and bottomed at 249.39% in Q3 2024.
- The 5-year median for EBT Margin is 30.04% (2024), against an average of 9.79%.
- Across the five-year window, EBT Margin surged 83822 bps in 2023 and slumped 96651 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 46.83% in 2022, then soared by 1790 bps to 885.05% in 2023, then plunged by 109 bps to 81.46% in 2024, then tumbled by 55 bps to 126.36% in 2025, then jumped by 92 bps to 9.92% in 2026.
- Per Business Quant, the three latest MRVI EBT Margin figures stand at 9.92% (Q1 2026), 126.36% (Q4 2025), and 108.45% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -9.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.92% |
| Dec 31, 2025 | -126.36% |
| Sep 30, 2025 | -108.45% |
| Jun 30, 2025 | -156.39% |
| Mar 31, 2025 | -112.47% |
| Dec 31, 2024 | -81.46% |
| Sep 30, 2024 | -249.39% |
| Jun 30, 2024 | -30.04% |
| Mar 31, 2024 | -34.92% |
| Dec 31, 2023 | 885.05% |
| Sep 30, 2023 | -30.75% |
| Jun 30, 2023 | -19.39% |
| Mar 31, 2023 | -5.72% |
| Dec 31, 2022 | 46.83% |
| Sep 30, 2022 | 59.48% |
| Jun 30, 2022 | 72.09% |
| Mar 31, 2022 | 68.30% |
| Dec 31, 2021 | 63.34% |
| Sep 30, 2021 | 73.74% |
| Jun 30, 2021 | 66.99% |